HR Execs on the Move

Accelmed Growth Partners

www.accelmed.co.il

 
Accelmed is an investment firm focused on value creation for medical device companies and technologies. Accelmed was founded in 2009 by Mori Arkin and Uri Geiger and invests in small and mid-cap private and public companies.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.accelmed.co.il
  • 400 Madison Avenue Suite 9B
    New York, NY USA 10017
  • Phone: 212.554.4601

Executives

Name Title Contact Details

Similar Companies

Megadyne Medical Products

Megadyne Medical Products is a Draper, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Paragon Intellectual Properties

Paragon Intellectual Properties is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

VQ OrthoCare

VQ OrthoCare is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

T2 Biosystems

At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.

Canadian Hospital Specialties

Canadian Hospital Specialties Ltd is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.